[Iatrogenic lupus: current status of the question. I. Clinical study and main drugs responsible].
D000974:Antibodies, Antinuclear / Q000032:analysis; D003276:Contraceptives, Oral / Q000009:adverse effects; D003937:Diagnosis, Differential; D006801:Humans; D006830:Hydralazine / Q000009:adverse effects; D007049:Iatrogenic Disease; D007538:Isoniazid / Q000009:adverse effects; D008180:Lupus Erythematosus, Systemic / Q000139:chemically induced* / Q000175:diagnosis; D008750:Methyldopa / Q000009:adverse effects; D011342:Procainamide / Q000009:adverse effects; D013449:Sulfonamides / Q000009:adverse effects
D000974:Antibodies, Antinuclear; D003276:Contraceptives, Oral; D013449:Sulfonamides; D006830:Hydralazine; D008750:Methyldopa; D011342:Procainamide; D007538:Isoniazid
Les lupus iatrogènes: état actuel de la question. I. Etude clinique et principaux produits incriminés.